46LOW

RNV

RENERVE FPO [RNV]
Healthcare · ASX Small Cap
$0.1150 +4.6%

Updated 2026-03-02 · Scores refresh every scan

Appeared in 2 consecutive scans→ Score -5First seen: 2026-02-25

Score Breakdown

Technical73
Catalyst51
Sentiment50
Fundamental41
Momentum63
Risk Gate45

Active Signals

Bullish Signals

  • Bollinger squeeze (breakout building)
  • Price above MAs (uptrend)
  • Volatility contracting (breakout setup)
  • Above 200-day MA (long-term uptrend)
  • Low cash runway (4 quarters) - dilution risk
  • Very high P/S ratio (56.5x)
  • Strong revenue growth (+60%)
  • Near 52-week low (12% of range)
  • Micro-cap ($5-20M) - high risk
  • Capital raise activity (2 events)
  • Dilution velocity warning (2 raises recently)
  • CANSLIM S: Tight float (44%)
  • Strong revenue momentum (+60%)
  • Elevated dilution risk (2 recent capital raises)
  • ASX200 bullish (+1.5% 5d)
  • RBA cutting (+2pts)
  • Dilution risk: technical breakout with recent capital raise

Risk Signals

  • Insufficient sentiment data (defaulting to neutral)
  • Neutral/mixed sentiment

Recent Catalysts

NONE 1HFY26 Results Announcement
NONE 1HFY26 Appendix 4D and Half Year Report
NONE Cleansing notice

Recent ASX Announcements

2026-02-25 1HFY26 Results Announcement PRICE SENSITIVE
2026-02-25 1HFY26 Appendix 4D and Half Year Report PRICE SENSITIVE
2026-02-17 Cleansing notice
2026-02-17 Application for quotation of securities - RNV
2026-02-16 Proposed issue of securities - RNV

Key Metrics

$18.8M
Market Cap
185K
Avg Volume
1.0x
Vol Ratio
$0.09 — $0.22
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-74.9%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 44%
LLeader vs LaggardpassRS: 3
IInstitutional SponsorshipweakInst: 1%
MMarket DirectionpassBullish

Sector: Healthcare

Ranked #96 of 119 · Sector avg: 51

View all Healthcare signals →
Related Tickers
AVE 66CUV 64NEU 60HLS 59IMM 59

Sign up free to unlock RNV analysis

Score breakdowns, signals, catalysts, and full analysis for 2,200+ ASX small caps. All features free during early access.

No credit card required. Unsubscribe anytime.
Already have access? Log in